# Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

> **NCT00058474** · PHASE3 · UNKNOWN · sponsor: **NSABP Foundation Inc** · enrollment: 1608 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** fluorouracil
- **DRUG:** oxaliplatin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00058474
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-07
- **Primary completion:** 2013-08
- **Final completion:** 2016-05
- **Target enrollment:** 1608 (ACTUAL)
- **Last updated:** 2016-03-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00058474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00058474, "Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00058474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*